tirzepatide head to head semaglutide outperforms in NEJM trial for weight loss | Yousaf A posted on the topic The Weight Loss Showdown: Semaglutide

The treatment arm achieved an 18 percent mean reduction in visceral adipose tissue versus a small increase in placebo, with statistically significant improvements in triglycerides (minus 50 mg/dL), total cholesterol, and patient-reported body image

If you want to have your order filled at a local pharmacy instead of via Ready Meds platform, please note that the local pharmacy may charge you a fee for your medication which Ready Med is unable to assist with

Myth two claims permanent transformation without effort

Furthermore, the review concludes that these drugs likely cause more brain inflammation and microbleeds than the placebo